Numerous studies have revealed distinct functions of Fos proteins in different mouse tissues and cell lines. Here, we perform a direct comparison of the features of exogenous c-Fos, Fra-1 and Fra-2 proteins expressed in murine tumor cells of epithelial origin, CSML0. Although transactivation potential of c-Fos is much stronger than that of Fra-1 and Fra-2, all three proteins are capable of modulating transcription of target genes. Moreover, there is a certain degree of specificity in the induction of the transcription of AP-1-responsive genes by different Fos proteins. For instance, c-Fos and Fra-1 but not Fra-2 activated genes of the urokinase system. Additionally, not only a strong transcriptional activator c-Fos, but also Fra-1 induced morphological alterations in CSML0 cells. N-terminal domain of Fra-1 was required for this function. On the other hand, Fra-2 failed to change morphology of CSML0 cells. We therefore conclude that c-Fos, Fra-1 and Fra-2 differently activate transcription of target genes and induce morphological changes in epithelioid carcinoma cells in a manner not directly linked to their transactivation potentials.
tors CBP/p300, or JAB1 (reviewed in Karin et al., 1997) . As many genes involved in tumor cell invasion are AP-1-dependent under certain circumstances, AP-1 has been broadly implicated in tumor progression. Central bZIP domains, which specify interaction with Jun and binding to TREs, are very conserved among Fos proteins (Wisdom and Verma, 1993) . This reflects the absence of significant differences between Fos proteins in their ability to form dimers with different Jun family members and to interact with different TREs. Studies performed in rodent fibroblasts have revealed multiple transactivation motifs in N-and Cterminal domains of c-Fos and FosB, but not in Fra-1 and Fra-2, in agreement with the low level of amino acid conservation in these regions (reviewed in Tulchinsky, 2000) . Numerous experiments with c-Fos mutants have demonstrated that the ability to transform rodent fibroblasts is indissociable from the ability of c-Fos to act as a transcriptional activator. Consistent with the theory that the transforming potential is linked with the transactivation function, Fra-1, Fra-2 or FosB2 proteins were not capable of producing a fully transformed phenotype either in 208F, or in Rat-1A fibroblasts (Wisdom and Verma, 1993; Bergers et al., 1995) . On the other hand, more recent data highlight the key role of non-transforming Fos proteins in src and ras-mediated transformation of fibroblasts (Mechta et al., 1997; Murakami et al., 1997 Murakami et al., , 1999 . In addition, it has been shown that the enhanced expression of Fra-1 correlates with the malignant phenotype of epithelial tumors and tumor cell lines (Vallone et al., 1997; Risse-Hackl et al., 1998; Battista et al., 1998; Kustikova et al., 1998; Chiappetta et al., 2000; Debinski et al., 2001; Zajchowski et al., 2001) .
Previously, we found that the ectopic expression of Fra-1 in murine epithelioid adenocarcinoma cells, CSML0, alters cell shape and activates transcription of several tumor progression markers. On the other hand, the effect of exogenous Fra-1 on an artificial AP-1 dependent promoter was relatively weak in these cells (Kustikova et al., 1998) . This observation prompted us to question, whether the ability to produce phenotypic alterations in epithelial cells totally depends on transactivation potential of a given Fos protein. Here we aimed to perform a direct comparison of the effects of ectopic expression in CSML0 cells of three Fos proteins, c-Fos, Fra-1 and Fra-2, which differ by their abilities to activate AP-1-responsive reporters in rodent fibroblasts. Since the level of endogenous AP-1 complex (c-Fos/JunD) is very low in CSML0 cells due to the decreased level of Fos, rather than the Jun component (Kustikova et al., 1998) , these cells represent a satisfactory model to study the features of exogenous Fos proteins in transformed epithelia. To compare the abilities of c-Fos, Fra-1 and Fra-2 proteins to activate a synthetic AP-1 dependent promoter, the pfLUCTRE65 construct was transfected into CSML0 cells along with the c-Fos, Fra-1 or Fra-2 expression vectors at different concentrations. Whilst Fra-1 and Fra-2 only moderately stimulated luciferase expression (with a factor of 3.8 and 6 for the Fra-1 and Fra-2 proteins correspondingly), c-Fos activated pfLUCTRE65 tremendously (a more than 3000-fold activation was observed, when 1 mg of pCMV-c-Fos DNA was applied) (Figure 1a ). The obtained data are in agreement with the previously reported lack of transactivation domains in Fra-1 and Fra-2 proteins (Wisdom and Verma, 1993; Bergers et al., 1995) . Previously, we have shown that Fra-1 induced alterations in cell shape when expressed in a CSML0 clone, 1f9 (Kustikova et al., 1998) . Knowing that Fra-1, Fra-2 and c-Fos possessed different transactivation potentials, we tested whether that correlated with their ability to affect cell morphology. We therefore evaluated morphological changes of CSML0 cells transfected with pCMV-c-Fos, pCMVFra-1 and pCMV-Fra-2 under the same conditions, in which the transactivation potentials of the Fos proteins had been estimated. Expression of c-Fos and Fra-1, but not Fra-2 changed the morphological appearance of CSML0 cells. Control vector-transfected cells displayed a round morphology, whereas c-Fos-and Fra-1-transfected cells exhibited more elongated morphology with cell extensions (Figure 1b) . In order to quantify changes in morphological appearance of transfected CSML0 cells, form factor, bipolarity index and process index (reviewed in Lepekhin et al., 2000) were determined. Form factor describes the roundness of a cell and varies from 1 (describing a circle) to 0. The bipolarity index reflects the degree of cellular elongation, whereas the process index indicates the number of processes/extensions. c-Fos and to a lesser extent Fra-1 altered cell shape as reflected by a decrease in form factor (to 83 and 91%, respectively) and an increase in process index (to 175 and 147%). cFos, but not Fra-1 altered bipolarity index (120 and 105% as compared with the bipolarity index of control cells), whereas the expression of Fra-2 did not affect morphology of CSML0 cells at all. In order to reveal a Fra-1 region responsible for morphological changes in CSML0 cells, we generated two constructs expressing truncated Fra-1 proteins which deleted either the entire N-terminal (Fra-1DN) or C-terminal (Fra-1DC) domains. The removal of 1 -94 aa N-terminal Fra-1 domain resulted in the functional inactivation of Fra-1. CSML0 cells transfected with Fra-1DN had nearly the same morphology as control cells, or cells expressing Fra-2 ( Figure 1c ). On the contrary, deleting C-terminal sequences (186 -273 aa) had an opposite effect and increased Fra-1 activity almost to the level of c-Fos. That is likely due to the significant enhancement of protein stability (data not shown) caused by the deletion of a Fra-1 COOH-terminal PEST motif, a conserved sequence involved in the rapid destruction of short-lived proteins.
Since the expression of Fra-1, Fra-2 and c-Fos proteins differently affected morphology of CSML0 cells, we assumed that these proteins also had different effects on the expression of AP-1-responsive genes. To test this hypothesis, we expressed each of these proteins in CSML0 cells using a retroviral vector, pMV-7. The cells infected with pMVfra-1, pMVfra-2, pMVc-fos or with an empty vector were maintained in the presence of G418. Neo-resistant cell populations were simultaneously subjected to RNA isolation and nuclear extracts preparation. Nuclear extracts were analysed for AP-1 binding activity using an end-labeled oligonucleotide containing collTRE. To visualize the composition of Fos proteins expressed in infected cell populations, specific anti-Fos antibodies or control antibody were added (Figure 2a ). The binding activity in all nuclear extracts was controlled by using an oligonucleotide containing a recognition sequence for the Oct-1 transcription factor, which is uniformly expressed in normal and different types of malignant epithelia (Jehn et al., 1992) . In addition, we examined the complexes formed with a consensus CRE, interacting with heterodimers of Jun and ATF/CREB family members. A complex with CRE that contained JunD (data not shown) and was characteristic for CSML0 cells was observed only in cells infected with the empty vector. In nuclear extracts prepared from cells infected with pMVc-fos, pMVfra-1 or pMVfra-2 the conventional complex was inhibited due to the binding of JunD to Fos component, but instead another more rapidly migrating complex appeared (Figure 2a ). The infection of CSML0 cells by any of three vectors harboring c-fos, fra-1 or fra-2 cDNA resulted in a similar increase in the intensity of the AP-1 complex as compared with cells infected with empty vector. The predominant Fos component of the AP-1 complex in CSML0 cells infected with empty vector was c-Fos, consistent with the data obtained in non-infected CSML0 cells (Kustikova et al., 1998) . In AP-1 complexes examined in cells infected with pMVc-fos, pMVfra-1 or pMVfra-2, the corresponding protein, cFos, Fra-1, or Fra-2, was detected as a predominant Fos component (Figure 2a ). Since AP-1 complexes in infected cells differed qualitatively, but not quantitatively, we used this model to compare the potentials of Fos proteins to activate transcription of AP-1-regulated genes. We have previously demonstrated that the induction of Fra-1 in a CSML0 subclone, 1f9, activated the transcription of five tumor progressionassociated genes, HMGI(Y), SY100A4, uPA, uPAR and PAI-1 (Kustikova et al., 1998) . The expression of Graphs show the values of form factor, bipolarity index and process domain. Form factor is defined as 4p6area/perimeter 2 and it is a measure of cellular roundness. Bipolarity index reflects degree of the cellular elongation and is defined as the ratio of cell length to the cell breadth. Process index is defined as the number of domains created by subtracting the object area from the convex hull area and is a measure of the number of cellular processed/extensions (Lepekhin et al., 2000) . Contours of 200 transfected cells were outlined by means of thresholding and binary transformation and used for determination of morphology parameters. Error bars correspond to the standard error of the mean. ****P50.0001 when compared to control pCMV-transfected cells these genes was therefore examined in the virusinfected cells. We could not observe activation of the S100A4 transcription in any of the infected CSML0 cells (data not shown), and the level of HMGI(Y) induction was considerably lower than that of 1f9 cells. This might be due to clonal peculiarities of 1f9 cells, or to the different duration of Fra-1 induction in DOXtreated 1f9 and CSML0/pMVfra-1 cells. Activation of the components of the urokinase system, uPA, uPAR and PAI-1 was observed in CSML0 cells transfected with vectors harboring fra-1 and c-fos as well. Remarkably, c-Fos and Fra-1 differed in their ability to activate transcription of uPA and uPAR. Whereas cFos had the most potent effect on uPAR transcription, uPA was more strongly activated by Fra-1 than by cFos (Figure 2b ). Fra-2 was a very weak activator of uPA and uPAR, and practically no stimulatory effect of Fra-2 on PAI-1, HMGI(Y) and S100A4 was seen. To create retroviral vectors expressing Fos proteins, the c-fos, fra-1 and fra-2 cDNAs were cloned into the HindIII-EcoRI sites of pMV-7 (Kirschmeier et al., 1988) , generating pMVc-fos, pMVfra-1 and pMVfra-2. To produce replication-defective retroviruses, we employed the GP+E packaging cell line (Markowitz et al., 1989) . Successfully transfected GP+E cells were selected in the presence of 800 mg/ml G418. Virus-containing supernatants of virus-producing cell lines were used to infect CSML0 cells. Infected cells were selected on 10-cm-diameter dishes for 10 days in the presence of 400 mg/ml G418. Next, the cells were split in two 75-cm 2 flasks for RNA isolation and preparation of nuclear extract. Nuclear extracts were prepared from subconfluent cultures of virus-infected cells as previously described (Kustikova et al., 1998) . The AP-1, ATF/CREB/Jun and Oct-1 complexes were detected with double-stranded end-labeled oligonucleotides containing TRE derived from the collagenase gene promoter (CGCTTGATGAGTCAGCCGGAA), Oct-1 binding site TGTCGAATG-CAAATCACTAGAA or the CRE consensus element AGAGATTGCCTGACGTCACGTCAGAGAGCTAG (Promega Corp). The reaction was carried out for 20 min, 308C. Anti-Fos or control antibodies (all purchased from Santa Cruz Biotechnology Inc.) were added to the EMSA reaction mixtures and the incubation was continued for 1 h at 48C. The complexes were analysed in nondenaturing polyacrylamid gels at 48C. (b) Transcription of Fos-inducible genes in infected cells. Total RNA was isolated from infected CSML0 cells using the acid guanidine thiocyanat method (Chomczynski and Sacchi, 1987) and analysed on Northern blots using the indicated 32 P-labeled probes. The references to hybridization probes specific for murine uPA, uPAR, PAI-1 and HMGI(Y) have been given previously (Kustikova et al., 1998) . To generate hybridization probes for CD44, osteopontin and thrombospondin-1, we amplified fragments of the coding parts of the genes by reverse transcription-PCR. Equal loading was controlled by hybridization to 32 P-labeled polyU. To search for genes activated by Fra-2, we applied Atlas Mouse Broad-Coverage cDNA Array 1.2 purchased from Clontech. We next attempted to test whether any genes were activated by Fra-2 in CSML0 cells. By using Clontech cDNA array blots we identified three genes, thrombospondin-1, osteopontin and CD44, which were obviously up-regulated in CSML0 cells infected with pMVfra-2. Enhanced transcription of these genes was also observed in cells infected with pMVc-fos and pMVfra-1 vectors (Figure 2b) . Therefore, in CSML0 cells c-Fos, Fra-1 and Fra-2 proteins are capable of activating transcription of responsive genes, albeit with different efficacy and specificity.
The key role of the AP-1 complex in oncogenic transformation and tumor progression is well documented (reviewed in Angel and Karin, 1991; Ozanne et al., 2000) . However, the view on the function of nontransforming Fos proteins in tumorigenesis contains an element of contradiction. Lacking transactivation domains Fra-1, Fra-2 and FosB2 are not efficient in transforming rodent fibroblasts. Moreover, Fra-2 and FosB2 inhibited a c-Fos-or FosB-mediated transactivation if a synthetic AP-1-dependent reporter (Suzuki et al., 1991; Jehn et al., 1991) . These data combined with the delayed activation of Fra-1 and Fra-2 in response to the stimulation by growth factors (Kovary and Bravo, 1992) allowed conceiving them as factors suppressing the AP-1 response. On the other hand, as Fra-1 is accumulated in AP-1 complexes in ras-transformed fibroblasts as well as during malignant progression of different types of tumors, it has been implicated in a maintenance and progression of the transformed state. This view is in agreement with the results obtained in rodent mammary and thyroid carcinoma cell lines, where the Fra-1 expression level was shown to affect cell features associated with the malignancy, such as invasiveness, motility and growth in soft agar (Vallone et al., 1997; Kustikova et al., 1998) .
Here we show that Fra-1, but not Fra-2 affected shape of epithelioid adenocarcinoma cells, CSML0, although both factors are relatively weak activators of a synthetic AP-1-responsive reporter pfLUC56TRE in the same cell line (Figure 1 ). In addition, Fra-1 and Fra-2 differed in the ability to activate transcription of responsive genes. Furthermore, a powerful activator of the pfLUC56TRE reporter c-Fos (Figure 1a ) was less efficient than Fra-1 in inducing uPA transcription. These data show the absence of a direct link between the potency of Fos proteins as transcriptional activators via isolated TREs and their ability to produce a physiological response in epithelioid cells (i.e. to alter cell shape and activate transcription of responsive genes).
Given that Fra-1 and Fra-2 only insignificantly induced the activity of the synthetic AP-1-responsive reporter, the molecular mechanism by which Fra-1 and Fra-2 proteins activate transcription remains unclear. Probably, in the molecular context of natural enhancers, Fos family members may exert their specific functions by recruiting other transcription factors different from Jun. If the N-terminal domains, which are not conserved in the Fos proteins are involved in such interactions, different Fos family members may achieve different effects in particular enhancers. This view is consistent with the ability of Fra-1 to rescue the differentiation block of c-fos 7/7 osteoclasts. This function, which is associated with the N-terminal Fra-1 domain, is more potent in Fra-1 than in the cFos protein (Matsuo et al., 2000) . Interestingly, the Nterminal Fra-1 domain is also essential for morphological alterations in CSML0 cells (Figure 1c) . Targeted disruption of the c-fos, fosB and fra-1 genes produced different phenotypes in mice. Whereas fosB 7/7 and cfos 7/7 mice were viable and fertile (Brown et al., 1996; Grigoriadis et al., 1994) , lack of fra-1 caused embryonic lethality due to the impaired vascularization of the labyrinth layer of the placenta (Schreiber et al., 2000) . The exact molecular mechanisms underlying the severe defects in fra-1 knockouts are not clear. However, the deregulated activity of two extracellular matrix degrading proteases, uPA and MMP-9, which are involved in the control of foeto-maternal interactions, was proposed to participate in the establishing of the fra-1 7/7 phenotype (Schreiber et al., 2000) . Interestingly, the transcription of uPA was more potently activated by Fra-1 than by c-Fos or Fra-2 in CSML0 cells (Figure 2b ). The expression of MMP-9 was not induced by any of the Fos proteins (data not shown). However, thrombospondin-1, which was also a preferential target for Fra-1 in CSML0 cells (Figure  2b ), has been shown to positively modulate the activity of MMP-9 in bovine endothelial cells (Qian et al., 1997) .
Different components of the MAP kinase pathway are often mutated in cancer resulting in the activation of the AP-1 transcription factor (reviewed in Wisdom, 1999; Ozanne et al., 2000) . Since the Fra-1 and Fra-2 proteins have different effects on gene transcription and epithelial cell shape, we assume that the observed enhanced expression of Fra-1 in highly malignant carcinomas results from the selection for Fra-1-expressing cells in the course of tumor progression.
